[go: up one dir, main page]

TW200503787A - Dermal delivery of a water-soluble selective cyclooxygenase-2 inhibitor - Google Patents

Dermal delivery of a water-soluble selective cyclooxygenase-2 inhibitor

Info

Publication number
TW200503787A
TW200503787A TW092132570A TW92132570A TW200503787A TW 200503787 A TW200503787 A TW 200503787A TW 092132570 A TW092132570 A TW 092132570A TW 92132570 A TW92132570 A TW 92132570A TW 200503787 A TW200503787 A TW 200503787A
Authority
TW
Taiwan
Prior art keywords
subject
active agent
composition
skin
backing sheet
Prior art date
Application number
TW092132570A
Other languages
English (en)
Inventor
Gary D Ewing
Guang-Wei Lu
Brenda M Stoller
Kathryn M Kienle
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of TW200503787A publication Critical patent/TW200503787A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW092132570A 2002-11-21 2003-11-20 Dermal delivery of a water-soluble selective cyclooxygenase-2 inhibitor TW200503787A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42820102P 2002-11-21 2002-11-21

Publications (1)

Publication Number Publication Date
TW200503787A true TW200503787A (en) 2005-02-01

Family

ID=32393362

Family Applications (1)

Application Number Title Priority Date Filing Date
TW092132570A TW200503787A (en) 2002-11-21 2003-11-20 Dermal delivery of a water-soluble selective cyclooxygenase-2 inhibitor

Country Status (15)

Country Link
US (1) US20040126415A1 (zh)
EP (1) EP1572166A1 (zh)
JP (1) JP2006509759A (zh)
AR (1) AR042102A1 (zh)
AU (1) AU2003291386A1 (zh)
BR (1) BR0316463A (zh)
CA (1) CA2506628A1 (zh)
GT (1) GT200300249A (zh)
MX (1) MXPA05004989A (zh)
NL (1) NL1024830C2 (zh)
PA (1) PA8589001A1 (zh)
PE (1) PE20041026A1 (zh)
TW (1) TW200503787A (zh)
UY (1) UY28086A1 (zh)
WO (1) WO2004047814A1 (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA012599B1 (ru) 2003-04-10 2009-10-30 Ньюроджескс, Инк. Способы и композиции для введения агонистов trpv1
US7666914B2 (en) * 2004-06-03 2010-02-23 Richlin David M Topical preparation and method for transdermal delivery and localization of therapeutic agents
ZA200707492B (en) * 2005-02-14 2009-02-25 Neurogesx Inc Device for delivery of TRPV1 agonists
CA2602832A1 (en) * 2005-03-30 2006-10-05 Keith R. Bley Low-concentration capsaicin patch and methods for treating neuropathic pain
DE102005050431A1 (de) * 2005-10-21 2007-04-26 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreicherung lipophiler und/oder wenig hautpermeabler Wirkstoffe
US20090081281A1 (en) * 2006-05-10 2009-03-26 Gerard Farmer Photosensitizer Formulation for Topical Applications
DE102006054732B4 (de) * 2006-11-21 2010-12-30 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit Ionenpaar-Mikroreservoiren
JP4327841B2 (ja) * 2006-12-20 2009-09-09 日東電工株式会社 経皮吸収製剤の製造装置および製造方法
WO2009143070A1 (en) * 2008-05-21 2009-11-26 Teikoku Pharma Usa, Inc. Treatment of dysmenorrhea via transdermal administration of nonsteroidal anti-inflammatory drugs
JP2012020991A (ja) * 2010-06-16 2012-02-02 Takasago Internatl Corp 経皮吸収促進剤、及びこれを含有する皮膚外用製剤
US9814911B2 (en) * 2011-07-15 2017-11-14 Robert Benson Aylor Skin and hair treatments
CA2966843A1 (en) * 2014-11-10 2016-05-19 Achelios Therapeutics, Inc. Sprayable analgesic compositions
KR102042456B1 (ko) * 2018-03-22 2019-11-08 크리스탈지노믹스(주) 경피흡수제제

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE03685B1 (et) * 1996-04-12 2002-04-15 G.D. Searle & Co. Asendatud benseensulfoonamiidi derivaadid kui COX-2 inhibiitorite eelravimid
US5952000A (en) * 1996-10-30 1999-09-14 Theratech, Inc. Fatty acid esters of lactic acid salts as permeation enhancers
ES2197077T3 (es) * 1999-03-01 2004-01-01 Amarin Technologies S.A. Dispositivo transdermico que comprende farmacos anti-inflamatorios no esteroides incorporados en una matriz de un polimero acrilico adhesivo.
US6309663B1 (en) * 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
IN191512B (zh) * 2000-01-21 2003-12-06 Panacea Biotech
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
AU2002306868A1 (en) * 2001-03-28 2002-10-15 Pharmacia Corporation Therapeutic combinations for cardiovascular and inflammatory indications
HUP0600294A2 (en) * 2001-05-31 2007-02-28 Pharmacia Corp Skin-permeable selective cyclooxygenase-2 inhibitor composition
JP4283507B2 (ja) * 2002-08-02 2009-06-24 久光製薬株式会社 経皮投与用貼付剤

Also Published As

Publication number Publication date
AU2003291386A1 (en) 2004-06-18
MXPA05004989A (es) 2005-08-02
US20040126415A1 (en) 2004-07-01
CA2506628A1 (en) 2004-06-10
EP1572166A1 (en) 2005-09-14
WO2004047814A1 (en) 2004-06-10
GT200300249A (es) 2004-07-12
NL1024830A1 (nl) 2004-05-26
BR0316463A (pt) 2005-10-11
AR042102A1 (es) 2005-06-08
PE20041026A1 (es) 2005-02-05
NL1024830C2 (nl) 2006-03-06
UY28086A1 (es) 2004-06-30
JP2006509759A (ja) 2006-03-23
PA8589001A1 (es) 2005-02-04

Similar Documents

Publication Publication Date Title
TW200503787A (en) Dermal delivery of a water-soluble selective cyclooxygenase-2 inhibitor
MXPA04001491A (es) Dispositivo de liberacion de farmaco erosionable mucoadhesivo para la administracion controlada de compuestos activos farmaceuticos y otros compuestos activos.
WO2005112984A3 (en) Apparatus and method for transdermal delivery of parathyroid hormone agents
WO2004078122A3 (en) Invisible patch for active agnet controlled delivery
BR0316275A (pt) Administração dérmica de um inibidor seletivo de ciclooxigenase-2, solúvel em água, por exemplo, parecoxibe e valdecoxibe
US20110008413A1 (en) Compositions and Methods of Topical Drug Delivery for the Treatment of Carpal Tunnel Syndrome
WO2007106597A3 (en) Method for the transdermal delivery of parathyroid hormone agents for treating osteopenia
BR9815378B1 (pt) sistema de fornecimento de droga transdérmico para agente analgésico antiinflamatório e método de fabricação do mesmo.
DK0957900T3 (da) Sammensætninger og fremgangsmåder til topisk påföring af terapeutiske midler
ATE288743T1 (de) Pharmazeutische trägervorrichtung welche zur verabreichung von wirkstoffen an schleimhautoberflächen geeignet ist
HUP9901991A2 (hu) Transzdermális eszköz flurbiprofén átadására
WO2005069758A3 (en) Frequency assisted transdermal agent delivery method and system
AU4923500A (en) Device and method for increasing the transdermal permeation of medicaments
AU622775B2 (en) A plaster used as therapeutic system for the administration of active substances to the skin, which exhibits a graduated active substance release, process for the production of the plaster and the use thereof
BRPI0417437A (pt) dispositivo para inibição da absorção, dispositivo para remoção de agente fisiologicamente ativo e dispositivo para redução do efeito de overdose
WO2011029948A3 (de) Transdermales therapeutisches system zur verabreichung von fentanyl oder einem analogstoff davon
WO2005102334A3 (en) Apparatus and method for transdermal delivery of fentany-based agents
DE50212336D1 (de) Transdermales therapeutisches system mit verbessertem langzeittragekomfort
DK1046395T3 (da) Plaster indeholdende heparin og diclofenac til topisk anvendelse
WO2006089056A3 (en) Apparatus and method for transdermal delivery of erythropoetin-based agents
WO2002017928A3 (de) Transdermales therapeutisches system zur abgabe von exemestan
HUP9904181A2 (hu) Felületstabilizált gyógyszerészeti készítmény bőrön való alkalmazáshoz
DOP2003000759A (es) Lamina revestida de adhesivo para administracion dermica de un inhibidor selectivo de ciclooxigenasa-2
DOP2003000758A (es) Administracion dermica de un inhibidor de ciclooxigenasa-2 selectivo soluble en agua
AU701327B2 (en) Preperation for the prophylaxis and/or treatment of wool and hair loss